Literature DB >> 12140788

Opposite modifications in circulating leptin and soluble leptin receptor across the eating disorder spectrum.

P Monteleone1, M Fabrazzo, A Tortorella, A Fuschino, M Maj.   

Abstract

Leptin is thought to modulate feeding behaviour, body weight and energy metabolism by acting through specific cellular receptors. Derangements of leptin production have been repeatedly reported in patients with anorexia nervosa (AN) or bulimia nervosa (BN), but no information has been provided on the functional status of leptin receptors in these disorders. Therefore, we measured plasma levels of leptin and its soluble receptor (Ob-Re) in a total of 130 women, including 22 patients with AN, 45 patients with BN, 18 patients with the binge-eating disorder (BED), 12 non-binge eating obese women and 33 healthy women. Circulating leptin was drastically reduced in underweight anorexics and normal-weight bulimics, but increased in overweight BED patients and non-binge-eating obese women. Conversely, plasma levels of Ob-Re were significantly increased in patients with AN or BN, but decreased in BED and non-binge-eating obese women. Significant inverse correlations were detected between plasma levels of leptin and those of Ob-Re in all the subject groups, except in non-binge-eating obese subjects. These results show, for the first time, that opposite modifications occur in circulating levels of leptin and Ob-Re across the eating-disorder spectrum. The relevance of these findings to the pathophysiology and treatment of eating disorders remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12140788     DOI: 10.1038/sj.mp.4001043

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  13 in total

Review 1.  Examining weight suppression as a transdiagnostic factor influencing illness trajectory in bulimic eating disorders.

Authors:  Pamela K Keel; Lindsay P Bodell; K Jean Forney; Jonathan Appelbaum; Diana Williams
Journal:  Physiol Behav       Date:  2019-05-30

Review 2.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

3.  Weight suppression and bulimic syndrome maintenance: Preliminary findings for the mediating role of leptin.

Authors:  Pamela K Keel; Lindsay P Bodell; Alissa A Haedt-Matt; Diana L Williams; Jonathan Appelbaum
Journal:  Int J Eat Disord       Date:  2017-10-16       Impact factor: 4.861

4.  Weight suppression in bulimia nervosa: Associations with biology and behavior.

Authors:  Lindsay P Bodell; Pamela K Keel
Journal:  J Abnorm Psychol       Date:  2015-07-20

5.  Leptin levels in patients with anorexia nervosa following day/inpatient treatment do not predict weight 1 year post-referral.

Authors:  Jochen Seitz; Katharina Bühren; Ronald Biemann; Nina Timmesfeld; Astrid Dempfle; Sibylle Maria Winter; Karin Egberts; Christian Fleischhaker; Christoph Wewetzer; Beate Herpertz-Dahlmann; Johannes Hebebrand; Manuel Föcker
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-02-05       Impact factor: 4.785

6.  Ghrelin: central and peripheral implications in anorexia nervosa.

Authors:  Mathieu Méquinion; Fanny Langlet; Sara Zgheib; Suzanne Dickson; Bénédicte Dehouck; Christophe Chauveau; Odile Viltart
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-26       Impact factor: 5.555

Review 7.  Leptin and its emerging role in children and adolescents.

Authors:  Iosif Kelesidis; Christos S Mantzoros
Journal:  Clin Pediatr Endocrinol       Date:  2006-02-22

8.  The role of BDNF, leptin, and catecholamines in reward learning in bulimia nervosa.

Authors:  Philipp Homan; Simona Grob; Gabriella Milos; Ulrich Schnyder; Anne Eckert; Undine Lang; Gregor Hasler
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-07       Impact factor: 5.176

9.  Leptin, soluble leptin receptor, and transforming growth factor-beta1 levels in minimal change nephrotic syndrome.

Authors:  Necla Buyan; Ozan Ozkaya; Aysun Bideci; Oğuz Söylemezoğlu; Peyami Cinaz; Sevim Gönen; Süleyman Kalman; Sevcan Bakkaloğlu; Enver Hasanoğlu
Journal:  Pediatr Nephrol       Date:  2003-07-29       Impact factor: 3.714

10.  Variation in plasma leptin levels in young Iranian children with cystic fibrosis.

Authors:  Maryam Monajemzadeh; Mohammad Taghi Haghi Ashtiani; Ehsan Sadrian; Sedigheh Shams; Farzaneh Motamed; Mehri Najafi Sani; Setareh Sadat Banihosseini; Ata Abbasi
Journal:  Arch Med Sci       Date:  2013-11-05       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.